Talanx AG (CHIX:TLXD) Research & Development: €0 Mil (TTM As of Mar. 2026)


CHIX:TLXD Talanx AG CHIX:TLXD
77 GF Score
Price €103.70
GF Value €102.55
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Talanx AG Research & Development?

Talanx AG CHIX:TLXD 77 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates CHIX:TLXD with a GF Score™ of 77/100 and a GF Value™ of €102.55 (Fairly Valued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Talanx AG's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Talanx AG  (CHIX:TLXd) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Talanx AG Research & Development Related Terms

Talanx AG Research & Development Historical Data

* Premium members only.

The historical data trend for Talanx AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talanx AG Research & Development Chart

Talanx AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Talanx AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:TLXD
77GF Score
Talanx AG CHIX:TLXD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Talanx AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Talanx AG (CHIX:TLXD) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Talanx AG and its competitors.
Is Talanx AG's Research & Development too high?
Talanx AG's current Research & Development is €0 Mil. Overall, Talanx AG has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Talanx AG's Research & Development compare to BRK.A and AIG?
Talanx AG's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Talanx AG and its competitors. Talanx AG's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Talanx AG stock overvalued right now?
Based on GuruFocus' analysis, Talanx AG (CHIX:TLXD) is currently considered Fairly Valued. The stock's GF Value™ is €102.55, compared to a current price of €103.70 — trading 1.1% above its estimated fair value. The current Research & Development is €0 Mil. Talanx AG's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Talanx AG (CHIX:TLXD), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Talanx AG (CHIX:TLXD) Overvalued in 2026?

Based on GuruFocus' analysis, Talanx AG stock appears to be overvalued. The current stock price of €103.70 is trading 1.1% above its estimated GF Value™ of €102.55. GuruFocus considers Talanx AG to be Fairly Valued.

Key valuation signals for CHIX:TLXD:

  • Research & Development: €0 Mil
  • GF Value™: €102.55 vs. price of €103.70 (1.1% above fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the CHIX:TLXD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Talanx AG Business Description

Address HDI-Platz 1, Hannover, NI, DEU, 30659
Talanx is the third largest insurer in Germany. It sells insurance to businesses, individuals, and reinsures other insurers. The origins of Talanx go back to the early 1900s and the founding of two mutuals in Germany, HDI and FSV, that were set up to provide liability insurance to the German iron and steel industry, and fire insurance to the German mining industry as a result of a growing dissatisfaction with providers of insurance. These two mutuals merged to form Halfplichtverband der Deutschen Industrie, or HDI, in 1970. Over the years companies outside of metals and mining have joined the mutual. HDI started providing reinsurance services in the mid-1920s, and individual insurance in the 1950s. HDI owns just over three-quarters of the Talanx share capital.
77GF Score

Get the complete analysis for CHIX:TLXD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€103.70
Price
€102.55
GF Value